Table 2. Predictive values for advanced liver fibrosis in patients infected with HBV.
PPV | NPV | Sensitivity | Specificity | Accuracy | |
---|---|---|---|---|---|
Serum miR-122 (< 71-fold) (n = 91) | 47% | 83% | 77% | 57% | 64% |
Serum WFA(+)-M2BP (> 1 C.O.I.) (n = 90) | 53% | 81% | 67% | 70% | 69% |
Serum miR-122 (< 71-fold) or serum WFA(+)-M2BP (> 1 C.O.I.) (n = 90) | 44% | 93% | 93% | 42% | 59% |
Serum miR-122 (< 71-fold) and serum WFA(+)-M2BP (> 1 C.O.I.) (n = 90) | 64% | 76% | 47% | 87% | 74% |
PPV, positive predictive value; NPV, negative predictive value